Positive: Liver Cancer Therapeutics market set to reach USD 15.69 billion by 2032, growing steadily.
From GlobeNewswire: 2025-02-18 09:50:00
The global Liver Cancer Therapeutics Market was valued at USD 3.12 Billion in 2023 and is projected to reach USD 15.69 Billion by 2032, growing at a CAGR of 19.21%. The surge in hepatocellular carcinoma cases is driving demand for effective treatments, with major players like Bayer AG, Roche Holding AG, and Merck & Co., Inc. leading the market.
In 2023, targeted therapy accounted for 56% of the market share, with targeted therapies providing more precise treatment with potentially fewer side effects than traditional chemotherapy. The Hepatocellular Carcinoma (HCC) segment held the largest market share of 38% in 2023, driven by the increasing global incidence of HCC and the development of new drugs for specific pathways.
Hospital pharmacies held a significant market share in 2023, serving as core diagnosis and treatment units for liver cancer. The rise in liver cancer patients has increased demand for specialized medications, with hospitals offering a wide range of therapeutic options and innovative treatments. North America accounted for 43% of the market share in 2023, with Asia-Pacific expected to be the fastest-growing region due to increasing cases of liver cancer and government initiatives for healthcare awareness. In August 2024, Bristol Myers Squibb’s sBLA for Opdivo in combination with Yervoy for unresectable HCC was accepted by the FDA. In April 2023, Roche’s Phase III IMbrave050 trial showed positive results for Tecentriq combined with Avastin for HCC patients, improving recurrence-free survival significantly.
The Liver Cancer Therapeutics Market Analysis & Outlook Report 2024-2032 offers insights into incidence, drug volume, healthcare spending, patient outcomes, and regional treatment accessibility. The report covers market dynamics, competitive landscape, therapy types, distribution channels, company profiles, and best practices for liver cancer therapeutics.
SNS Insider is a top market research and consulting agency providing clients with current market data, consumer insights, and opinions. Through surveys, video talks, and focus groups, we aim to equip clients with the knowledge needed to thrive in evolving market conditions. Access the full report for detailed analysis of the liver cancer therapeutics market.
Read more at GlobeNewswire: Liver Cancer Therapeutics Market to Hit USD 15.69 Billion